Publications by authors named "Meg Franklin"

Claim this Profile
I
Impact of on resource utilization and costs in patients with exacerbated non-cystic fibrosis bronchiectasis.
Meg Franklin, Michael E Minshall, Federica Pontenani, Sunjay Devarajan

J Med Econ· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICER report on Alzheimer's disease: implications from a patient perspective.
Meg Franklin

J Manag Care Spec Pharm· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneity in renal end points of cardiovascular outcomes trials in Type 2 diabetes.
Chakrapani Balijepalli, Kevin Yan, Michael Zoratti, Meg Franklin, Eric Druyts

J Comp Eff Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
ICER's assessment of lasmiditan, rimegepant, and ubrogepant for acute migraine.
Meg Franklin, Eric Druyts

J Manag Care Spec Pharm· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of type 2 diabetes mellitus and hyperlipidemia in patients prescribed dasatinib or nilotinib as first- or second-line therapy for chronic myelogenous leukemia in the US.
Meg Franklin, Leah Burns, Samuel Perez, Deepak Yerragolam, Dinara Makenbaeva

Curr Med Res Opin· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency and economic impact of comorbid cardiac conditions with multiple sclerosis.
Meg A Franklin, Laura E Happe, Rachel Dillman, Landon Z Marshall

J Manag Care Spec Pharm· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist management of patients with diabetes mellitus enrolled in a rural free clinic.
Julie M Sease, Meg A Franklin, Katherine R Gerrald

Am J Health Syst Pharm· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of natalizumab versus fingolimod for the treatment of relapsing multiple sclerosis.
Ken O'Day, Kellie Meyer, Ross M Miller, Sonalee Agarwal, Meg Franklin

J Med Econ· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of infliximab dosing in inflammatory bowel disease: results from a multicenter US chart review.
Heidi Waters, Julie Vanderpoel, Scott McKenzie, Orsolya Lunacsek, Meg Franklin

J Med Econ· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling costs and outcomes associated with a treatment algorithm for problem bleeding episodes in patients with severe hemophilia a and high-titer inhibitors.
Patrick Bonnet, Alessandro Gringeri, Edward Gomperts, Cindy Anne Leissinger, Roseline d'Oiron, Meg Franklin

Am Health Drug Benefits· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic and clinical evaluation of fondaparinux vs. enoxaparin for thromboprophylaxis following general surgery.
Robin Farias-Eisner, Ruslan Horblyuk, Meg Franklin, Orsolya E Lunacsek, Laura E Happe

Curr Med Res Opin· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consequences of major bleeding in hospitalized patients with non-ST segment elevation acute coronary syndromes receiving injectable anticoagulants.
Laura E Happe, Sunil V Rao, Ruslan Horblyuk, Meg Franklin, Orsolya E Lunacsek

Curr Med Res Opin· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of deep vein thrombosis in the outpatient setting following major orthopedic surgery.
Edith A Nutescu, Andrew F Shorr, Eileen Farrelly, Ruslan Horblyuk, Laura E Happe, Meg Franklin

Ann Pharmacother· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postdischarge oral versus injectable anticoagulation following major orthopedic surgery.
Andrew F Shorr, Edith A Nutescu, Eileen Farrelly, Ruslan Horblyuk, Laura E Happe, Meg Franklin

Ann Pharmacother· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managed care and the impact of glaucoma.
Claiborne E Reeder, Meg Franklin, Thomas J Bramley

Am J Manag Care· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current landscape of insomnia in managed care.
Claiborne E Reeder, Meg Franklin, Thomas J Bramley

Am J Manag Care· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The state of insomnia and emerging trends.
Thomas Roth, Meg Franklin, Thomas J Bramley

Am J Manag Care· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anxiety disorders in the 21st century: status, challenges, opportunities, and comorbidity with depression.
C Lindsay Devane, Evelyn Chiao, Meg Franklin, Eric J Kruep

Am J Manag Care· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis